Purple Biotech (PPBT) Retained Earnings (2014 - 2026)
Purple Biotech (PPBT) reported Retained Earnings of -$171.2 million for Q1 2026, down 17.93% year-over-year from -$208.6 million in Q1 2025, and little changed quarter-over-quarter from -$171.1 million in Q4 2025.
Purple Biotech (PPBT) Retained Earnings (2014 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 13 years of Retained Earnings data on file, last reported at -$171.2 million in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$171.2 million, down 17.93% year-over-year; the trailing twelve-month figure through Mar 2026 was -$171.2 million (down 17.93% YoY), and the FY2025 annual result was -$171.1 million, down 18.24% from the prior year.
- Retained Earnings steadied at -$171.2 million in Q1 2026 per PPBT's latest filing, from -$171.1 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$103.2 million in Q1 2022 and troughed at -$171.2 million in Q1 2026.
- A 5-year average of -$136.1 million and a median of -$141.2 million in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings slipped 22.82% in 2022, then fell 1.82% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$117.6 million in 2022, then declined by 16.91% to -$137.5 million in 2023, then retreated by 5.27% to -$144.7 million in 2024, then dropped by 18.24% to -$171.1 million in 2025, then retreated by 0.05% to -$171.2 million in 2026.
- Business Quant data shows PPBT's Retained Earnings at -$171.2 million in Q1 2026, -$171.1 million in Q4 2025, and -$147.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Purple Biotech | 261.30 Mn | 254.88 Mn | - | -171.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -171.17 Mn |
| Dec 31, 2025 | -171.08 Mn |
| Sep 30, 2025 | -147.53 Mn |
| Jun 30, 2025 | -146.23 Mn |
| Mar 31, 2025 | -145.15 Mn |
| Dec 31, 2024 | -144.69 Mn |
| Sep 30, 2024 | -144.28 Mn |
| Jun 30, 2024 | -143.62 Mn |
| Mar 31, 2024 | -141.22 Mn |
| Dec 31, 2023 | -137.45 Mn |
| Sep 30, 2023 | -132.63 Mn |
| Jun 30, 2023 | -127.59 Mn |
| Mar 31, 2023 | -122.45 Mn |
| Dec 31, 2022 | -117.57 Mn |
| Sep 30, 2022 | -111.56 Mn |
| Jun 30, 2022 | -106.74 Mn |
| Mar 31, 2022 | -103.20 Mn |
| Dec 31, 2021 | -95.91 Mn |
| Sep 30, 2021 | -90.83 Mn |
| Jun 30, 2021 | -87.70 Mn |